235 related articles for article (PubMed ID: 12708882)
1. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
Safar ME; Struijker-Boudier HA
Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
[TBL] [Abstract][Full Text] [Related]
2. [Predictors of cardiovascular mortality and morbidity in hypertension].
Laurent S
Curr Med Res Opin; 2005; 21 Suppl 5():S7-11. PubMed ID: 16197646
[TBL] [Abstract][Full Text] [Related]
3. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
Houston MC
Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
[TBL] [Abstract][Full Text] [Related]
4. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
5. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic outlooks in the treatment of the hypertensive patient].
Ambrosioni E; Bacchelli S; Borghi C
Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
[TBL] [Abstract][Full Text] [Related]
7. Systolic blood pressure: it's time to take control.
Franklin SS
Am J Hypertens; 2004 Dec; 17(12 Pt 2):49S-54S. PubMed ID: 15607435
[TBL] [Abstract][Full Text] [Related]
8. Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion.
Mourad JJ; Laville M
J Hypertens Suppl; 2006 Aug; 24(5):S10-6. PubMed ID: 16936530
[TBL] [Abstract][Full Text] [Related]
9. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
10. Importance of improving tissue perfusion during treatment of hypertension.
Lévy B
J Hypertens Suppl; 2006 Aug; 24(5):S6-9. PubMed ID: 16936534
[TBL] [Abstract][Full Text] [Related]
11. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
Agabiti-Rosei E
Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension and microcirculation].
Boudier HA
Arch Mal Coeur Vaiss; 2002 Sep; 95 Spec No 6():17-22. PubMed ID: 12407782
[TBL] [Abstract][Full Text] [Related]
13. Large-artery stiffness, hypertension and cardiovascular risk in older patients.
Blacher J; Safar ME
Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):450-5. PubMed ID: 16265585
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
15. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
17. Are current strategies for treating hypertension effective?
Sica DA
J Clin Hypertens (Greenwich); 2003; 5(3 Suppl 2):23-32. PubMed ID: 12826767
[TBL] [Abstract][Full Text] [Related]
18. Prevention of atherosclerosis and end-organ damage: a basis for antihypertensive interventional strategies.
Schwartz CJ; Valente AJ; Hildebrandt EF
J Hypertens Suppl; 1994 Jul; 12(5):S3-11. PubMed ID: 7965284
[TBL] [Abstract][Full Text] [Related]
19. [Role of microcirculation in hypertension].
Vicaut E
Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):636-42. PubMed ID: 12555470
[TBL] [Abstract][Full Text] [Related]
20. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
